V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20192335 | 20123921 | 1.82 | 55 | Palliative (P) | 2018-09-13 | 2018-09-13 | Cetuximab + FLUOROURACIL + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101388766 |
| 20192336 | 20123922 | 1.75 | 56.5 | Adjuvant (A) | 2016-06-12 | 2016-06-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100377771 |
| 20192337 | 20123923 | 1.66 | 64.4 | Palliative (P) | 2018-10-23 | 2018-11-03 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100704860 |
| 20192341 | 20123924 | 1.74 | 68.1 | Palliative (P) | 2019-11-14 | 2019-11-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101640861 |
| 20192345 | 20123925 | 1.7 | 71.9 | Palliative (P) | 2016-12-14 | 2016-12-23 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100009901 |
| 20192349 | 20123926 | null | 56.5 | null | 2017-03-18 | 2017-04-01 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101139833 |
| 20192352 | 20123927 | 1.67 | 53.1 | Curative (C) | 2018-11-08 | 2018-11-08 | Docetaxel | 02 | N | DOCETAXEL | 100472903 |
| 20192353 | 20123928 | 1.63 | 70 | null | 2017-08-24 | 2017-09-13 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101557641 |
| 20192357 | 20123929 | 1.66 | null | Palliative (P) | null | 2018-10-18 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101855606 |
| 20192358 | 20123930 | 1.67 | 59 | Adjuvant (A) | 2018-06-22 | 2018-06-23 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100086075 |
| 20192359 | 20123931 | 1.68 | 65.4 | Palliative (P) | 2019-10-31 | 2019-11-07 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100349125 |
| 20192362 | 20123932 | 1.79 | 56 | null | 2016-08-16 | 2017-01-27 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100773986 |
| 20192369 | 20123933 | 1.63 | 71.4 | Palliative (P) | 2017-06-07 | 2017-06-08 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100006141 |
| 20192372 | 20123934 | 1.89 | 53.3 | null | 2016-07-21 | 2016-08-04 | CETUXIMAB + IRINOTECAN + MDG | N | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100851378 |
| 20192379 | 20123935 | 1.73 | 114 | Palliative (P) | null | 2018-01-14 | Docetaxel | 02 | N | DOCETAXEL | 101577526 |
| 20192380 | 20123936 | 1.73 | 88.2 | null | 2017-06-06 | 2017-06-20 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101122018 |
| 20192383 | 20123937 | null | 133.7 | Palliative (P) | 2019-09-14 | 2019-11-08 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100561516 |
| 20192384 | 20123938 | 1.77 | 78 | Palliative (P) | 2017-03-13 | 2017-08-06 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100956961 |
| 20192386 | 20123939 | 1.9 | 86 | Palliative (P) | 2019-10-26 | 2019-11-07 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100181783 |
| 20192387 | 20123940 | 1.72 | 70 | Palliative (P) | 2018-08-01 | 2018-08-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101449236 |
| 20192388 | 20123941 | null | 80.6 | Neo-adjuvant (N) | 2017-06-11 | 2017-06-12 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100609588 |
| 20192406 | 20123942 | 1.7 | 70.75 | null | 2018-12-13 | 2019-01-14 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 101705343 |
| 20192418 | 20123943 | 1.72 | 56.5 | Adjuvant (A) | 2018-11-17 | 2019-05-15 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100375008 |
| 20192419 | 20123944 | 1.93 | 66.5 | Palliative (P) | 2019-12-15 | 2019-12-15 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101152007 |
| 20192422 | 20123945 | 1.81 | 74 | null | 2018-02-23 | 2018-03-09 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101149590 |
| 20192423 | 20123946 | 1.52 | 84 | Palliative (P) | 2016-08-05 | 2016-08-06 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100564256 |
| 20192424 | 20123947 | 1.76 | 84 | Palliative (P) | 2018-10-11 | 2019-03-25 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100696115 |
| 20192427 | 20123948 | 1.84 | 55 | null | 2020-07-02 | 2020-09-07 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100207400 |
| 20192428 | 20123949 | 1.69 | 88 | Palliative (P) | 2018-09-26 | 2018-10-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100057355 |
| 20192431 | 20123950 | 1.7 | 104.3 | Palliative (P) | 2016-06-18 | 2016-12-16 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101373717 |
| 20192433 | 20123951 | 1.67 | null | Palliative (P) | 2019-05-29 | 2019-06-20 | CETUXIMAB + IRINOTECAN + FLUOROURACIL | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100301002 |
| 20192434 | 20123952 | null | 91.3 | Palliative (P) | 2016-07-05 | 2016-11-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100455545 |
| 20192438 | 20123953 | 1.69 | 68.3 | Palliative (P) | 2019-11-15 | 2020-03-24 | CETUXIMAB + IRINOTECAN + MDG | N | N | DOCETAXEL | 101087089 |
| 20192445 | 20123954 | 1.69 | 108 | null | 2018-06-28 | 2018-08-06 | Cetuximab + FOLFIRI cycle1 | 02 | null | DOCETAXEL | 100170423 |
| 20192447 | 20123955 | 1.88 | 60.1 | Palliative (P) | 2016-11-28 | 2018-03-28 | Docetaxel 75mg/m2 (21 day) | 2 | N | DOCETAXEL | 100297047 |
| 20192448 | 20123956 | 1.88 | 65.1 | Adjuvant (A) | 2018-01-24 | 2018-01-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100543530 |
| 20192449 | 20123957 | null | null | 03 | null | 2019-04-12 | CETUXIMAB + IRINOTECAN + MDG | N | N | DOCETAXEL | 100754598 |
| 20192459 | 20123958 | 1.6 | 75.1 | Palliative (P) | 2014-12-20 | 2017-01-21 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101252885 |
| 20192461 | 20123959 | 1.74 | 79.7 | Palliative (P) | 2018-09-02 | 2018-09-16 | Gemcitabine + Capecitabine | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101292158 |
| 20192462 | 20123960 | 1.63 | 73.5 | Palliative (P) | 2019-01-06 | 2019-03-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101187167 |
| 20192464 | 20123961 | 1.67 | 51.6 | Neo-adjuvant (N) | 2019-01-31 | 2019-02-05 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | DOCETAXEL | 100073596 |
| 20192467 | 20123962 | 1.66 | 73 | Palliative (P) | 2021-12-24 | 2022-01-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100486581 |
| 20192469 | 20123963 | 1.85 | 90.3 | Palliative (P) | 2016-11-02 | 2016-11-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101543432 |
| 20192470 | 20123964 | null | 95 | null | 2017-03-06 | 2017-03-20 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | null | DOCETAXEL | 101376494 |
| 20192474 | 20123965 | 1.86 | 79.2 | Palliative (P) | 2018-11-13 | 2018-11-22 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100751462 |
| 20192475 | 20123966 | 1.7 | 59.2 | Neo-adjuvant (N) | 2016-10-08 | 2016-11-03 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DOCETAXEL | 100580384 |
| 20192476 | 20123967 | 1.62 | 95 | null | 2020-01-05 | 2020-01-16 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101686040 |
| 20192477 | 20123968 | 1.67 | 63.5 | Palliative (P) | 2018-11-06 | 2018-11-08 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100113673 |
| 20192478 | 20123969 | 1.63 | 77.9 | Palliative (P) | 2016-05-13 | 2016-06-11 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100096113 |
| 20192480 | 20123970 | 1.77 | 64.4 | null | null | 2016-04-19 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101805801 |